Cognito Therapeutics

Cambridge, United States · Founded 2016 · $198.0M raised

Headquarters
Cambridge
Founded
2016
Business Model
B2B2C
Total Funding
$198.0M
Last Round
$105.0M Series CMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cognito Therapeutics is a Cambridge, Massachusetts clinical-stage neurotechnology company founded in 2016 by MIT researchers Ed Boyden and Li-Huei Tsai, based on their discovery that sensory stimulation can evoke gamma-wave brain activity linked to Alzheimer's progression. Its non-invasive Spectris device delivers light-and-sound gamma stimulation and received FDA Breakthrough Device Designation in 2021; the company is advancing pivotal clinical trials aimed at slowing cognitive decline in Alzheimer's patients.

Summary

Cognito Therapeutics is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $198.0M in total across 3 rounds, most recently a $105.0M Series C round in Mar 2026. Investors include IAG Capital Partners, Starbloom Capital and Morningside Group.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2026
$105.0M

Sign up to see all 3 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cognito Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cognito-therapeutics"><img src="https://indexed.vc/api/badge/company/cognito-therapeutics" alt="Cognito Therapeutics on Indexed.vc" width="260" height="76" /></a>